PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsBreakthrough in stem cell research - world's first reprogrammed adult cell

BioNews

Breakthrough in stem cell research - world's first reprogrammed adult cell

Published 12 December 2012 posted in News and appears in BioNews 628

Author

Dr Louisa Petchey

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

US scientists have for the first time created 'personalised' human embryonic stem cells (hESCs) using a form of cloning. The result is a significant milestone on the route to using stem cell-based therapies but the researchers stress more work is to be done as genetic errors in the cells means they are not yet suitable for therapeutic use....

US scientists have for the first time created 'personalised' human embryonic stem cell (hESCs) using a form of cloning. The result is a significant milestone on the route to using stem cell-based therapies but the researchers stress more work is to be done as genetic errors in the cells means they are not yet suitable for therapeutic use.

Dr Dieter Egli, lead researcher at the New York Stem Cell Foundation Laboratory, who was involved in the study, told the BBC: 'There is clearly more work to be done, this is early days'. But he said the findings mark 'a step on that road' towards taking patient-specific stem cells into the clinic where they could one day be used to replace damaged tissues without the risk of rejection by the body.

The researchers used a technique called SCNT to create an egg that contains genetic material taken from the intended recipient of the resulting stem cells. The egg then reprograms the cell so that it begins to divide like a developing embryo to produce a blastocyst from which stem cells can be collected.

SCNT has been successful in animals — Dolly the sheep was the first animal to be cloned from an adult cell - but research so far demonstrates the technique does not work efficiently for human cells. Previous studies have shown that the egg often stops dividing and dies after nuclear transfer and despite some progress being made, any hESCs produced have not been suitable for therapeutic use.

But what Dr Egli and colleagues have shown is that human cells can be reprogrammed by SCNT - but only if the genetic material of the egg itself is left inside the cell. This is an exciting breakthrough, but the down side is that the resultant stem cells contained three sets of chromosomes rather than the usual two. Despite the extra chromosome set, the stem cells were capable of differentiating into germ layers but this error makes them unsuitable for anything other than research.

But there is good news: 'While this approach does not itself provide a solution, it takes us a step closer to understanding where the problems lie', explained Professor Mary Herbert from the Institute of Ageing and Health at Newcastle University. This means that the hunt is on to find out exactly what is required from the egg's genome to reprogram the cell and how to supply it.

SCNT, however, requires a steady supply of donated human eggs which raises practical and ethical issues of donation. The New York Times reports that Dr Egli secured a reliable supply through collaboration with a clinic associated with Columbia University in New York which paid donors $8,000. Although the US National Academy of Sciences has issued guidelines which say donors should not be paid, the state of New York allows donors to receive reasonable compensation for eggs donated for research in an effort to encourage donors to come forward.

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
25 April 2014 • 2 minutes read

Human cloning first: stem cells created from adult skin cells

by Sarah Pritchard

Scientists have used a cloning technique to successfully create human embryonic stem cells from adult cells for the first time...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
16 May 2013 • 3 minutes read

Human embryonic stem cells created via cloning

by Dr Rosie Morley

Embryonic stem cells have been created from human skin cells for the first time by US scientists using a cloning technique...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
4 February 2013 • 4 minutes read

Radio Review: The Life Scientific - Professor Sir John Gurdon

by Dr Rachael Panizzo

Shortly after being awarded the 2012 Nobel prize in physiology or medicine, Professor Sir John Gurdon was interviewed for the BBC Radio 4 programme 'The Life Scientific'...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 January 2013 • 2 minutes read

Stem cells for lung repair identified and tested in mice

by Dr Rachael Panizzo

Stem cells that are able to regenerate damaged lung tissue have been discovered by scientists. The brochioalveolar stem cells (BASCs), naturally present in the lungs of rodents and humans, are capable of rebuilding alveoli - the small air sacs in lungs...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 December 2012 • 2 minutes read

Gene mutation for liver disease corrected in human stem cells

by Luciana Strait

Genetics and stem cell research have been combined for the first time to correct a genetic mutation associated with liver disease. This new approach could lead to people with a genetic disease being treated with their own cells....

PET BioNews
Comment
2 February 2010 • 4 minutes read

From Dolly the sheep to embryo selection: reflecting on a decade of progress in genetics and assisted reproduction

by Mark Henderson

Some things never change. When the first issue of BioNews appeared on 29 March, 1999, the second item announced that an Italian doctor was claiming to have helped ten infertile men to become fathers, by cultivating their sperm in the testicular tissue of rats. Just this morning, I was asked...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
27 October 2009 • 2 minutes read

Conviction for cloning scientist Hwang Woo-Suk

by Dr Antony Starza-Allen

A South Korean court has convicted disgraced stem cell scientist, Hwang Woo-Suk, of embezzling funds and purchasing human eggs for research, after a trial lasting over three years. Hwang was given a two-year sentence suspended for three years by the Seoul Central District Court last week...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
1 September 2009 • 1 minute read

Disgraced Korean scientist faces four years in prison

by Nishat Hyder

Disgraced scientist, Hwang Woo-suk found last Monday that he faces a possible four year jail term for alleged embezzlement, and the violation of Korean bioethics law....

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
9 June 2009 • 2 minutes read

South Korea ends moratorium on embryonic stem cell research

by Heidi Colleran

South Korea's Presidential Committee on Bioethics has granted the first human embryonic stem (ES) cell research licence since their preeminent research scientist fell spectacularly from grace amidst allegations of scientific fraud and embezzlement, over three years ago. Cha Medical Center in the South Korean capital, Seoul, has...

PET BioNews
News
9 June 2009 • 2 minutes read

South Korea rejects Hwang's application to continue human stem cell research

by Dr Antony Starza-Allen

The South Korean Health Ministry has rejected a licence application to carry out stem cell research made by the company owned by disgraced stem cell scientist, Hwang Woo-Suk, citing 'ethical problems'. The Suam Biotech Research Foundation had requested approval last December to resume its research on human...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Gene for a 'heavy heart' found in rodents

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856